|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Galapagos Genomics NV Announces Exclusive Agreement With Upstate For Marketing And Sales Of Adenovirus Products
5/17/2006 4:49:26 PM
Galapagos NV (Euronext & LSE: GLPG) announced today that its service division BioFocus has signed an exclusive marketing & sales agreement with Upstate, a wholly-owned subsidiary of Serologicals Corporation (NASDAQ: SERO), for Galapagos’ adenovirus products worldwide, excluding Japan. Under the terms of the agreement, Upstate, a leader in cell signaling products and services for the drug discovery industry, will put its manufacturing, marketing, sales, customer support and technical assistance organization behind promotion of Galapagos’ adenovirus products. In return, Galapagos will receive double-digit royalties on net sales achieved by Upstate.
|
|
|
|
|
|
|
|
|
|
|